Skip to content

Albert Katchborian‐neto

3 papers in the library · 71 citations · publishing 2020-2025

Papers

Sort Most recent Most cited

Dimethyltryptamine and harmine, components of ayahuasca, prevented cocaine-induced apoptosis in SH-SY5Y human neuroblastoma cells

Archives of Toxicology November 12, 2025 Gilles Salles, Carolina Aparecida de Faria Almeida, Isabella de Carvalho Alves et al.

Ayahuasca is a psychoactive brew traditionally used in religious rituals by indigenous Amazonian populations and South American syncretic religions such as Santo Daime and União do Vegetal. Its psychoactive effects are primarily due to N,N-dimethyltryptamine (DMT), while harmine (HRE), a β-carboline alkaloid, inhibits monoamine oxidase (MAO), enabling DMT's oral bioavailability. Recent studies...

Immunological Modulation and Control of Parasitaemia by Ayahuasca Compounds: Therapeutic Potential for Chagas's Disease

Chemistry & Biodiversity September 26, 2022 Albert Katchborian‐neto, Mário F. C. Santos, Diego Fernandes Vilas Boas et al. 9 citations

Abstract Ayahuasca is a psychoactive and psychedelic decoct composed mainly of Banisteriopsis caapi and Psychotria viridis plant species. The beverage is rich in alkaloids and it is ritualistically used by several indigenous communities of South America as a natural medicine. There are also reports in the literature indicating the prophylaxis potential of Ayahuasca alkaloids against internal...

Neuroprotective potential of Ayahuasca and untargeted metabolomics analyses: applicability to Parkinson's disease.

Journal of Ethnopharmacology June 12, 2020 Albert Katchborian‐neto, Wanderleya T Santos, Karen J Nicácio et al. 62 citations

Ayahuasca is a tea produced through decoction of Amazonian plants. It has been used for centuries by indigenous people of South America. The beverage is considered to be an ethnomedicine, and it is traditionally used for the treatment of a wide range of diseases, including neurological illness. Besides, some scientific evidence suggests it may be applicable to Parkinson's disease (PD)...